Bristol Myers Squibb and Microsoft announced on Tuesday a partnership aimed at accelerating the early detection of lung cancer using artificial intelligence across the U.S. healthcare system. The collaboration will be implemented through Microsoft’s Precision Imaging Network, a platform that analyzes X-ray and CT scans using FDA-cleared AI algorithms.
China is exploring the creation of a national mergers and acquisitions (M&A) fund to support the development of key technologies — from robotics to artificial intelligence — as competition with the United States for technological leadership intensifies. The idea was announced by Wang Changlin, Vice Chairman of the National Development and Reform Commission (NDRC), during a press briefing, although no detailed parameters have yet been disclosed.
At the World Economic Forum in Davos, technology leaders agreed that 2026 will mark the transition of artificial intelligence from pilot projects to large-scale deployment. The speed and safety of this shift will depend on three factors: access to energy, cybersecurity, and companies’ ability to integrate AI with critical decision-making systems.
New scientific studies indicate that nanoparticles based on rare-earth metals may have potential in the diagnosis and treatment of brain tumors, particularly glioblastoma, one of the most aggressive cancers, with a median patient survival of around 12–15 months.